Allergan, Inc.

Allergan, Inc. is among the world’s largest Pharmaceuticals sector businesses in the world. Allergan, Inc.’s employees generate $361.2M in profits on $3.324B of revenue. Global output in the Pharmaceuticals business will likely rise substantially over the next 10 years. Long-term economic growth may lift all boats, but Allergan, Inc. is determined to remain a market leader. Sectoral leadership in the Pharmaceuticals segment takes dedication and consistency, but management seeks out-sized growth.

Allergan, Inc.’s ticker symbol AGN has recently been trading near $57.44 a share. The Allergan, Inc. corporate headquarters in Irvine, CA predicts Pharmaceuticals profits will satisfy shareholders in search of risk-appropriate returns.

The significance of market volume is sometimes ignored, but with a total market capitalization of $17.524B ensures sufficient liquidity. With a beta of 1.88, the company is more volatile than the market as a whole. When the average equity moves higher, Allergan, Inc. moves more aggressively.